Abstract
A survey was conducted to study the experiences of patients with false positive results for colorectal cancer. The study patients were participants in a randomized trial of compliance with different methods of colorectal cancer screening by faecal occult blood testing. Fifty four out of fifty six patients (96.4%) with false positive results agreed to be interviewed. An age and sex matched control group of 112 patients with negative test results was identified --92 (82.1%) returned questionnaires. Thirteen of the patients with false positive results (24.1%) and 19 controls (20.7%) were to some extent distressed by the initial letter inviting them to participate in the screening programme. Thirty seven of the patients with false positive results (68.5%) felt some degree of distress at the initial positive test result and 19 (35.2%) some distress because of delays experienced in the process of being screened. Ten false positive patients had colonoscopy and the median waiting time for this procedure was 10 days--half of the patients found this wait distressing. Nevertheless, 53 of the patients with false positive results (98.1%) felt that it had been worthwhile to have had the test. Generally, colorectal screening was as acceptable to the patients who experienced false positive results as to those with negative results.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Blalock S. J., DeVellis B. M., Sandler R. S. Participation in fecal occult blood screening: a critical review. Prev Med. 1987 Jan;16(1):9–18. doi: 10.1016/0091-7435(87)90002-8. [DOI] [PubMed] [Google Scholar]
- Bloom J. R., Monterossa S. Hypertension labeling and sense of well-being. Am J Public Health. 1981 Nov;71(11):1228–1232. doi: 10.2105/ajph.71.11.1228. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fleischer D. E., Goldberg S. B., Browning T. H., Cooper J. N., Friedman E., Goldner F. H., Keeffe E. B., Smith L. E. Detection and surveillance of colorectal cancer. JAMA. 1989 Jan 27;261(4):580–585. [PubMed] [Google Scholar]
- Frank J. W. Occult-blood screening for colorectal carcinoma: the benefits. Am J Prev Med. 1985 May-Jun;1(3):3–9. [PubMed] [Google Scholar]
- Frank J. W. Occult-blood screening for colorectal carcinoma: the risks. Am J Prev Med. 1985 Jul-Aug;1(4):25–32. [PubMed] [Google Scholar]
- Love R. R., Camilli A. E. The value of screening. Cancer. 1981 Jul 15;48(2 Suppl):489–494. doi: 10.1002/1097-0142(19810715)48:1+<489::aid-cncr2820481309>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
- Marteau T. M., Kidd J., Cook R., Johnston M., Michie S., Shaw R. W., Slack J. Screening for Down's syndrome. BMJ. 1988 Dec 3;297(6661):1469–1469. doi: 10.1136/bmj.297.6661.1469-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Marteau T. M. Psychological costs of screening. BMJ. 1989 Aug 26;299(6698):527–527. doi: 10.1136/bmj.299.6698.527. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stoate H. G. Can health screening damage your health? J R Coll Gen Pract. 1989 May;39(322):193–195. [PMC free article] [PubMed] [Google Scholar]